In fact, IL-8 expression has been detected in numerous cancer types, but its value as a cancer biomarker has been poorly investigated, even though it could be relevant for a good number of malignant diseases such as thyroid cancers where IL-8 represents the most deeply investigated chemokine in thyroid tumor microenvironment (77). This evidence concerns the gene CXCL8 and thyroid cancer.